These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 28089701)

  • 1. Functionalized triazines as potent HCV entry inhibitors.
    Mull ES; Sun LQ; Zhao Q; Eggers B; Pokornowski K; Zhai G; Rajamani R; Jenkins S; Kramer M; Wang YK; Fang H; Tenney D; Baldick CJ; Cockett MI; Meanwell NA; Scola PM
    Bioorg Med Chem Lett; 2017 Feb; 27(4):1089-1093. PubMed ID: 28089701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel small-molecule inhibitors of hepatitis C virus entry block viral spread and promote viral clearance in cell culture.
    Coburn GA; Fisch DN; Moorji SM; de Muys JM; Murga JD; Paul D; Provoncha KP; Rotshteyn Y; Han AQ; Qian D; Maddon PJ; Olson WC
    PLoS One; 2012; 7(4):e35351. PubMed ID: 22545104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of highly potent small molecule Hepatitis C Virus entry inhibitors.
    Mittapalli GK; Jackson A; Zhao F; Lee H; Chow S; McKelvy J; Wong-Staal F; Macdonald JE
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6852-5. PubMed ID: 21978675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships of 4-hydroxy-4-biaryl-proline acylsulfonamide tripeptides: A series of potent NS3 protease inhibitors for the treatment of hepatitis C virus.
    Wang AX; Chen J; Zhao Q; Sun LQ; Friborg J; Yu F; Hernandez D; Good AC; Klei HE; Rajamani R; Mosure K; Knipe JO; Li D; Zhu J; Levesque PC; McPhee F; Meanwell NA; Scola PM
    Bioorg Med Chem Lett; 2017 Feb; 27(3):590-596. PubMed ID: 28011221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, activity, and pharmacokinetic properties of a series of conformationally-restricted thiourea analogs as novel hepatitis C virus inhibitors.
    Kang IJ; Wang LW; Yeh TK; Lee CC; Lee YC; Hsu SJ; Wu YS; Wang JC; Chao YS; Yueh A; Chern JH
    Bioorg Med Chem; 2010 Sep; 18(17):6414-21. PubMed ID: 20675142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Derivatives of imidazotriazine and pyrrolotriazine C-nucleosides as potential new anti-HCV agents.
    Draffan AG; Frey B; Fraser BH; Pool B; Gannon C; Tyndall EM; Cianci J; Harding M; Lilly M; Hufton R; Halim R; Jahangiri S; Bond S; Jeynes TP; Nguyen VT; Wirth V; Luttick A; Tilmanis D; Pryor M; Porter K; Morton CJ; Lin B; Duan J; Bethell RC; Kukolj G; Simoneau B; Tucker SP
    Bioorg Med Chem Lett; 2014 Nov; 24(21):4984-8. PubMed ID: 25288185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a series of 1,3,4-trisubstituted pyrazoles as novel hepatitis C virus entry inhibitors.
    Hwang JY; Kim HY; Park DS; Choi J; Baek SM; Kim K; Kim S; Seong S; Choi I; Lee HG; Windisch MP; Lee J
    Bioorg Med Chem Lett; 2013 Dec; 23(23):6467-73. PubMed ID: 24125883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and In Vitro anti-HCV and Antitumor Evaluation of Schisandronic Acid Derivatives.
    Zhang KX; Qian XJ; Zheng W; Cai MC; Ma Y; Zhang DZ; Yu SC; Meng QG; Jin YS
    Med Chem; 2021; 17(9):974-982. PubMed ID: 32819233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of bivalent oleanane-type triterpenes as potent HCV entry inhibitors.
    Yu F; Peng Y; Wang Q; Shi Y; Si L; Wang H; Zheng Y; Lee E; Xiao S; Yu M; Li Y; Zhang C; Tang H; Wang C; Zhang L; Zhou D
    Eur J Med Chem; 2014 Apr; 77():258-68. PubMed ID: 24650713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and structure-activity relationships study of novel thieno[2,3-b]pyridine analogues as hepatitis C virus inhibitors.
    Wang NY; Zuo WQ; Xu Y; Gao C; Zeng XX; Zhang LD; You XY; Peng CT; Shen Y; Yang SY; Wei YQ; Yu LT
    Bioorg Med Chem Lett; 2014 Mar; 24(6):1581-8. PubMed ID: 24529869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and SAR of pyridothiazole substituted pyrimidine derived HCV replication inhibitors.
    Girijavallabhan VM; Alvarez C; Bennett F; Chen L; Gavalas S; Huang Y; Kim SH; Kosinski A; Pinto P; Rizvi R; Rossman R; Shankar B; Tong L; Velazquez F; Venkatraman S; Verma VA; Kozlowski J; Shih NY; Piwinski JJ; MacCoss M; Kwong CD; Bansal N; Clark JL; Fowler AT; Kezar HS; Valiyaveettil J; Reynolds RC; Maddry JA; Ananthan S; Secrist JA; Li C; Chase R; Curry S; Huang HC; Tong X; Njoroge FG; Arasappan A
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5652-7. PubMed ID: 22858143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent inhibitors of the hepatitis C virus NS3 protease: use of a novel P2 cyclopentane-derived template.
    Johansson PO; Bäck M; Kvarnström I; Jansson K; Vrang L; Hamelink E; Hallberg A; Rosenquist A; Samuelsson B
    Bioorg Med Chem; 2006 Aug; 14(15):5136-51. PubMed ID: 16675222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of 2-iminobenzimidazoles as potent hepatitis C virus inhibitors with a novel mechanism of action.
    Windisch MP; Jo S; Kim HY; Kim SH; Kim K; Kong S; Jeong H; Ahn S; No Z; Hwang JY
    Eur J Med Chem; 2014 May; 78():35-42. PubMed ID: 24675178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The discovery of indole derivatives as novel hepatitis C virus inhibitors.
    Han Z; Liang X; Wang Y; Qing J; Cao L; Shang L; Yin Z
    Eur J Med Chem; 2016 Jun; 116():147-155. PubMed ID: 27061978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry.
    Lin LT; Chung CY; Hsu WC; Chang SP; Hung TC; Shields J; Russell RS; Lin CC; Li CF; Yen MH; Tyrrell DL; Lin CC; Richardson CD
    J Hepatol; 2015 Mar; 62(3):541-8. PubMed ID: 25450204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of novel pentacyclic triterpene α-cyclodextrin conjugates as HCV entry inhibitors.
    Xiao S; Wang Q; Si L; Zhou X; Zhang Y; Zhang L; Zhou D
    Eur J Med Chem; 2016 Nov; 124():1-9. PubMed ID: 27565552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel HCV inhibitors: synthesis and biological activity of 6-(indol-2-yl)pyridine-3-sulfonamides targeting hepatitis C virus NS4B.
    Zhang X; Zhang N; Chen G; Turpoff A; Ren H; Takasugi J; Morrill C; Zhu J; Li C; Lennox W; Paget S; Liu Y; Almstead N; Njoroge FG; Gu Z; Komatsu T; Clausen V; Espiritu C; Graci J; Colacino J; Lahser F; Risher N; Weetall M; Nomeir A; Karp GM
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3947-53. PubMed ID: 23683597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action.
    Calland N; Sahuc ME; Belouzard S; Pène V; Bonnafous P; Mesalam AA; Deloison G; Descamps V; Sahpaz S; Wychowski C; Lambert O; Brodin P; Duverlie G; Meuleman P; Rosenberg AR; Dubuisson J; Rouillé Y; Séron K
    J Virol; 2015 Oct; 89(19):10053-63. PubMed ID: 26202241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analogs design, synthesis and biological evaluation of peptidomimetics with potential anti-HCV activity.
    Lasheen DS; Ismail MA; Abou El Ella DA; Ismail NS; Eid S; Vleck S; Glenn JS; Watts AG; Abouzid KA
    Bioorg Med Chem; 2013 May; 21(10):2742-55. PubMed ID: 23583031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and characterization of a novel 7-aminopyrazolo[1,5-a]pyrimidine analog as a potent hepatitis C virus inhibitor.
    Hwang JY; Windisch MP; Jo S; Kim K; Kong S; Kim HC; Kim S; Kim H; Lee ME; Kim Y; Choi J; Park DS; Park E; Kwon J; Nam J; Ahn S; Cechetto J; Kim J; Liuzzi M; No Z; Lee J
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7297-301. PubMed ID: 23159569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.